Skip to main content
. 2016 Mar 9;6:23. doi: 10.1186/s13550-016-0173-z

Table 3.

A: C-index analysis of with and without the addition of BSI to blood based biomarkers at baseline. B: C-index analysis of change in BSI and PSA at treatment follow-up

C-index Confidence interval SE
A. Baseline analysisa (dead/total = 56/80)
 BSI 0.71 0.64–0.77 0.03
 PSA 0.65 0.57–0.72 0.03
 ALP 0.67 0.58–0.75 0.03
 HgB 0.26 0.20–0.32 0.03
 PSA + ALP + HgB 0.67 0.58–0.74 0.03
 PSA + ALP + HgB + BSI 0.72 0.64–0.78 0.03
B. Change (∆) at week 12 (dead/total = 40/62)
 ∆ BSI 0.75 0.68–0.81 0.05
 ∆ PSA 0.73 0.66–0.78 0.05
 ∆ PSA + ∆ BSI 0.77 0.71–0.82 0.05

aBSI, PSA, ALP, and HgB values were observed skewed and therefore logarithmically transformed